{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:24:46Z","timestamp":1776399886738,"version":"3.51.2"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.thromres.2025.109411","type":"journal-article","created":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T14:06:32Z","timestamp":1753625192000},"page":"109411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Anticoagulant therapy for cancer-associated splanchnic vein thrombosis: Outcomes during a one-year follow-up period"],"prefix":"10.1016","volume":"253","author":[{"given":"Adrian","family":"Garcia-Villa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Criado-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Carnevali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Aramberri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carme","family":"Font","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"D\u00edaz-Pedroche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2025.109411_bb0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.thromres.2012.08.259","article-title":"Clinical approach to splanchnic vein thrombosis: risk factors and treatment","volume":"130","author":"Riva","year":"2012","journal-title":"Thromb. Res."},{"issue":"05","key":"10.1016\/j.thromres.2025.109411_bb0010","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1055\/s-0035-1550439","article-title":"Splanchnic vein thrombosis","volume":"41","author":"Valla","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"issue":"13","key":"10.1016\/j.thromres.2025.109411_bb0015","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.3748\/wjg.v12.i13.2115","article-title":"Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies","volume":"12","author":"Ogren","year":"2006","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109411_bb0020","first-page":"371","article-title":"Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer","volume":"106","author":"Menapace","year":"2011","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109411_bb0025","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1055\/s-0035-1550429","article-title":"Risk factors, diagnosis, management, and outcome of splanchnic vein thrombosis: a retrospective analysis","volume":"41","author":"Derman","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"issue":"2","key":"10.1016\/j.thromres.2025.109411_bb0030","first-page":"200","article-title":"Survival and recurrence in patients with splanchnic vein thromboses","volume":"8","author":"Thatipelli","year":"2010","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"issue":"1","key":"10.1016\/j.thromres.2025.109411_bb0035","first-page":"99","article-title":"Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry","volume":"40","author":"Ageno","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2025.109411_bb0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.thromres.2021.03.018","article-title":"Splanchnic vein thrombosis: Clinical manifestations, risk factors, management, and outcomes","volume":"202","author":"Kawata","year":"2021","journal-title":"Thromb. Res."},{"issue":"15","key":"10.1016\/j.thromres.2025.109411_bb0045","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1182\/bloodadvances.2022007961","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis","volume":"6","author":"Candeloro","year":"2022","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.thromres.2025.109411_bb0050","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1160\/th15-04-0326","article-title":"Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment","volume":"115","author":"De Stefano","year":"2016","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2025.109411_bb0055","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamainternmed.2015.3184","article-title":"Long-term clinical outcomes of splanchnic vein thrombosis: results of an international registry","volume":"175","author":"Ageno","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.thromres.2025.109411_bb0060","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/VHRM.S197732","article-title":"Splanchnic vein thrombosis: current perspectives","volume":"15","author":"Valeriani","year":"2019","journal-title":"Vasc. Health Risk Manag."},{"issue":"4","key":"10.1016\/j.thromres.2025.109411_bb0065","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1160\/TH16-10-0781","article-title":"Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome","volume":"117","author":"Ageno","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2025.109411_bb0070","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clinre.2018.10.014","article-title":"Epidemiology of Budd-Chiari syndrome: a systematic review and meta-analysis","volume":"43","author":"Li","year":"2019","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109411_bb0075","first-page":"7","article-title":"Cancer statistics, 2018: cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.thromres.2025.109411_bb0080","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood.2020006827","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis","volume":"137","author":"Valeriani","year":"2021","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.thromres.2025.109411_bb0085","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/jth.14836","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation","volume":"18","author":"Di Nisio","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109411_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtha.2024.01.019","article-title":"Natural history of cancer-associated splanchnic vein thrombosis","volume":"22","author":"Shang","year":"2024","journal-title":"J. Thromb. Haemost."},{"issue":"24","key":"10.1016\/j.thromres.2025.109411_bb0095","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1182\/bloodadvances.2024014249","article-title":"Impact of thrombocytopenia on bleeding and thrombotic outcomes in adults with cancer-associated splanchnic vein thrombosis","volume":"8","author":"Andersen","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2025.109411_bb0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.thromres.2019.11.023","article-title":"Splanchnic vein thrombosis predicts worse survival in patients with advanced pancreatic cancer","volume":"185","author":"Afzal","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2025.109411_bb0105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.thromres.2023.10.002","article-title":"Cancer-associated splanchnic vein thrombosis: Clinical features upon diagnosis and short-term outcomes","volume":"231","author":"Garc\u00eda-Villa","year":"2023","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2025.109411_bb0110","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.thromres.2023.09.004","article-title":"Breaking down tumor thrombus: current strategies for medical management","volume":"230","author":"Tathireddy","year":"2023","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2025.109411_bb0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jtha.2024.10.002","article-title":"Management and outcomes in patients with tumor thrombus: a retrospective cohort study","volume":"23","author":"Hui","year":"2025","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109411_bb0120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.thromres.2023.12.014","article-title":"Cancer-associated splanchnic vein thrombosis: clinical implications and management considerations","volume":"234","author":"Cohen","year":"2024","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2025.109411_bb0125","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/jth.15214","article-title":"Clinical history of cancer-associated splanchnic vein thrombosis","volume":"19","author":"Valeriani","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109411_bb0130","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the study of liver diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.thromres.2025.109411_bb0135","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.thromres.2025.109411_bb0140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-230X-7-34","article-title":"Portal vein thrombosis; risk factors, clinical presentation and treatment","volume":"15","author":"Sogaard","year":"2007","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109411_bb0145","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1182\/asheducation-2014.1.318","article-title":"Management of incidental splanchnic vein thrombosis in cancer patients","volume":"2014","author":"Kreuziger","year":"2014","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"3","key":"10.1016\/j.thromres.2025.109411_bb0150","first-page":"285","article-title":"Clinical outcome of portal vein thrombosis in patients with digestive cancers: a large AGEO multicenter study","volume":"50","author":"Regnault","year":"2018","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"issue":"1","key":"10.1016\/j.thromres.2025.109411_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261671","article-title":"Clinical characteristics and disease course of splanchnic vein thrombosis in gastrointestinal cancers: a prospective cohort study","volume":"17","author":"Kang","year":"2022","journal-title":"PLoS One"},{"issue":"Supplement_1","key":"10.1016\/j.thromres.2025.109411_bb0160","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1182\/blood-2019-124476","article-title":"Natural history of tumor thrombus: a single-centre retrospective study","volume":"134","author":"Marcoux","year":"2019","journal-title":"Blood"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:29:18Z","timestamp":1761406158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825001616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":32,"alternative-id":["S0049384825001616"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109411","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulant therapy for cancer-associated splanchnic vein thrombosis: Outcomes during a one-year follow-up period","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109411","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109411"}}